Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

31 mai 2022 07h39 HE | Source: Axsome Therapeutics, Inc.

Axsome Therapeutics Announces Publication of Pivotal GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder in The Journal of Clinical Psychiatry

NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
23 oct. 2013 09h35 HE | Source: Shareholders Foundation, Inc.

Deadline on December 2, 2013 in Lawsuit for Investors in J.C. Penney Company, Inc. (JCP) Shares Announced by Shareholders Foundation

SAN DIEGO, Oct. 23, 2013 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a deadline to get actively involved is coming up on December 2, 2013 in the lawsuit filed on behalf of...